Archive for the ‘Beijing Med-Pharm Corp. BGJP’ Category

Beijing Med-Pharm Corp. (BGJP) is “One to Watch”

Monday, June 23rd, 2008

BMP Sunstone, formerly Beijing Med-Pharm, is a Delaware corporation licensed in 2003 with Chinese subsidiaries offering comprehensive solutions to western pharmaceutical companies hoping to sell in the Chinese marketplace.

In 2004, a change in China’s corporate law enabled the former Beijing Med-Pharm to buy Beijing Wanwei Pharmaceutical Corp., Ltd. The result was BMP Sunstone, which provides a variety of services to foreign pharmaceutical companies, including pre-market entry analysis, clinical trial management to meet China’s pharmaceutical standards, pharmaceutical registration (including pre-registration), marketing services, and distribution to the bulk of China’s more than 13,000 hospitals.

With U.S. headquarters in Philadelphia, Pennsylvania, and operations throughout the Peoples Republic of China, BMP Sunstone is positioned to open doors for emerging and established pharmaceutical manufacturers and sellers to the Chinese marketplace, which has begun to explode and promises to become the world’s fifth largest pharmaceutical marketplace by 2010, with projected annual sales of $120 billion (U.S. dollars) by 2020, according to Sinopharma Group, a leading domestic pharmaceutical company.

More and more western pharmaceutical companies like AstraZeneca recognize the long-term business opportunities presented by this burgeoning marketplace. To date, all 20 top multinational pharmaceutical giants have either established or expanded their presence in the country, leading to an 80-percent dominance of China’s pharmaceutical market by foreign-made drugs, according to the WTO Tribune.

In addition to its marketing services, BMP Sunstone is also building a portfolio of proprietary drugs for sale within China, beginning with Propess and Anpo, or ritodrine hydrochloride, a muscle relaxant. These, together with its seasoned team of professionals in management positions and portfolio of services to help western pharmaceutical companies enter China’s emerging medicinal marketplace, place BMP Sunstone in an enviable position to deliver value to both Chinese consumers and shareholders.

Let us hear your thoughts: Beijing Med-Pharm Corp. Message Board

Beijing Med-Pharm Corp. (BGJP) is “One to Watch”

Wednesday, December 19th, 2007

Based in Plymouth Meeting, Pennsylvania, Beijing Med-Pharm Corp. (NASDAQ: BGJP) operates through its subsidiaries to provide pharmaceutical marketing and distribution for U.S. and western pharmaceutical companies wishing to reach the People’s Republic of China. The company offers marketing and promotional services to hospitals and other healthcare providers, and distribution services for western medicines, traditional Chinese medicines, bio-chemical medicines and more.

Beijing Med-Pharm’s product profile includes Propess, a vaginal insert used to “ripen” the cervix to prepare for induced childbirth; Anpo (ritodrine hydrochloride), a muscle relaxant for pre-term labor management; Misopess, a vaginal insert for cervical ripening and the induction of labor; and Fentora buccal tablets for pain management for cancer patients.

The company recently entered into an agreement with Shanghai Novartis Trading Ltd. to sell overactive bladder treatment Enablex in China. Per the agreement, Beijing Med-Pharm is expected to approach China’s State Food and Drug Association for exclusive rights to sell and market the drug in China for 10 years. Already on the market in the U.S., Enablex is used to treat urinary incontinence, urgency and frequency to those afflicted with an overactive bladder.

The company is governed by Martyn Greenacre, chairman of the board since July 2004, who brings more than 10 years of pharmaceutical management experience to the table; David Gao, CEO, who has held various positions at Motorola, including vice president and director of the Integrated Electronic System Sector; and Fred Powell, CFO, who comes to Beijing Med-Pharm with nearly 24 years of experience in financial services.

Let us hear your thoughts: Beijing Med-Pharm Corp. Message Board